ES2540151A1 - Composición farmacéutica de ibuprofeno y tramadol para uso oftálmico - Google Patents
Composición farmacéutica de ibuprofeno y tramadol para uso oftálmico Download PDFInfo
- Publication number
- ES2540151A1 ES2540151A1 ES201300963A ES201300963A ES2540151A1 ES 2540151 A1 ES2540151 A1 ES 2540151A1 ES 201300963 A ES201300963 A ES 201300963A ES 201300963 A ES201300963 A ES 201300963A ES 2540151 A1 ES2540151 A1 ES 2540151A1
- Authority
- ES
- Spain
- Prior art keywords
- tramadol
- ibuprofen
- pharmaceutical composition
- translation
- machine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- TVYLLZQTGLZFBW-ZBFHGGJFSA-N (R,R)-tramadol Chemical compound COC1=CC=CC([C@]2(O)[C@H](CCCC2)CN(C)C)=C1 TVYLLZQTGLZFBW-ZBFHGGJFSA-N 0.000 title abstract 3
- HEFNNWSXXWATRW-UHFFFAOYSA-N Ibuprofen Chemical compound CC(C)CC1=CC=C(C(C)C(O)=O)C=C1 HEFNNWSXXWATRW-UHFFFAOYSA-N 0.000 title abstract 3
- 229960001680 ibuprofen Drugs 0.000 title abstract 3
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 3
- 229960004380 tramadol Drugs 0.000 title abstract 3
- TVYLLZQTGLZFBW-GOEBONIOSA-N tramadol Natural products COC1=CC=CC([C@@]2(O)[C@@H](CCCC2)CN(C)C)=C1 TVYLLZQTGLZFBW-GOEBONIOSA-N 0.000 title abstract 3
- 206010061218 Inflammation Diseases 0.000 abstract 2
- 230000004054 inflammatory process Effects 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 206010015958 Eye pain Diseases 0.000 abstract 1
- 208000002193 Pain Diseases 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 230000001575 pathological effect Effects 0.000 abstract 1
- 238000001356 surgical procedure Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Ophthalmology & Optometry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Dermatology (AREA)
- Emergency Medicine (AREA)
- Dispersion Chemistry (AREA)
- Biomedical Technology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Abstract
Composición farmacéutica de ibuprofeno y tramadol para uso oftálmico. La presente invención se refiere a una composición farmacéutica de ibuprofeno y tramadol para uso oftálmico. Dicha composición resulta eficaz y segura para el tratamiento de la inflamación y/o el dolor ocular asociados a diversas enfermedades o estados patológicos que afectan a la zona ocular. En particular, la composición oftálmica de la invención está indicada, por ejemplo, para el tratamiento del dolor y/o la inflamación tras cirugía ocular.
Description
Claims (1)
-
imagen1 imagen2 imagen3 imagen4
Priority Applications (14)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ES201300963A ES2540151B1 (es) | 2013-10-11 | 2013-10-11 | Composición farmacéutica de ibuprofeno y tramadol para uso oftálmico |
MX2014012158A MX355770B (es) | 2013-10-11 | 2014-10-08 | Composicion farmaceutica de ibuprofeno y tramadol para uso oftalmico. |
EP14380031.6A EP2862565B1 (en) | 2013-10-11 | 2014-10-10 | Pharmaceutical composition of ibuprofen and tramadol for ophthalmological use |
HUE14380031A HUE040093T2 (hu) | 2013-10-11 | 2014-10-10 | Ibuprofén és tramadol gyógyászati kompozíciója szemgyógyászati alkalmazásra |
PT14380031T PT2862565T (pt) | 2013-10-11 | 2014-10-10 | Composição farmacêutica de ibuprofeno e tramadol para utilização oftalmológica |
DK14380031.6T DK2862565T3 (en) | 2013-10-11 | 2014-10-10 | Pharmaceutical composition of ibuprofen and tramadol for ophthalmic use |
PL14380031T PL2862565T3 (pl) | 2013-10-11 | 2014-10-10 | Farmaceutyczna kompozycja ibuprofenu i tramadolu do zastosowania w okulistyce |
US14/511,321 US10292953B2 (en) | 2013-10-11 | 2014-10-10 | Pharmaceutical composition of ibuprofen and tramadol for ophthalmic use |
BR102014025307-6A BR102014025307B1 (pt) | 2013-10-11 | 2014-10-10 | Composição farmacêutica de ibuprofeno e tramadol para uso oftálmico |
ARP140103790A AR097997A1 (es) | 2013-10-11 | 2014-10-10 | Composición farmaceutica de ibuprofeno y tramadol para uso oftálmico |
ES14380031.6T ES2685023T3 (es) | 2013-10-11 | 2014-10-10 | Composición farmacéutica de ibuprofeno y tramadol para uso oftálmico |
RU2014140885A RU2694369C2 (ru) | 2013-10-11 | 2014-10-10 | Фармацевтическая композиция ибупрофена и трамадола для офтальмологического применения |
HRP20181282TT HRP20181282T1 (hr) | 2013-10-11 | 2018-08-03 | Farmaceutski pripravak ibuprofena i tramadola, namijenjen očnoj upotrebi |
CY181100867T CY1120642T1 (el) | 2013-10-11 | 2018-08-17 | Φαρμακευτικη συνθεση της ιβουπροφαιμνης και της τραμαδολης για οφθαλμολογικη χρηση |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ES201300963A ES2540151B1 (es) | 2013-10-11 | 2013-10-11 | Composición farmacéutica de ibuprofeno y tramadol para uso oftálmico |
Publications (2)
Publication Number | Publication Date |
---|---|
ES2540151A1 true ES2540151A1 (es) | 2015-07-08 |
ES2540151B1 ES2540151B1 (es) | 2016-02-29 |
Family
ID=51868157
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES201300963A Active ES2540151B1 (es) | 2013-10-11 | 2013-10-11 | Composición farmacéutica de ibuprofeno y tramadol para uso oftálmico |
ES14380031.6T Active ES2685023T3 (es) | 2013-10-11 | 2014-10-10 | Composición farmacéutica de ibuprofeno y tramadol para uso oftálmico |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES14380031.6T Active ES2685023T3 (es) | 2013-10-11 | 2014-10-10 | Composición farmacéutica de ibuprofeno y tramadol para uso oftálmico |
Country Status (13)
Country | Link |
---|---|
US (1) | US10292953B2 (es) |
EP (1) | EP2862565B1 (es) |
AR (1) | AR097997A1 (es) |
BR (1) | BR102014025307B1 (es) |
CY (1) | CY1120642T1 (es) |
DK (1) | DK2862565T3 (es) |
ES (2) | ES2540151B1 (es) |
HR (1) | HRP20181282T1 (es) |
HU (1) | HUE040093T2 (es) |
MX (1) | MX355770B (es) |
PL (1) | PL2862565T3 (es) |
PT (1) | PT2862565T (es) |
RU (1) | RU2694369C2 (es) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2604816A1 (es) * | 2015-09-09 | 2017-03-09 | Farmalider, S.A. | Composición farmacéutica de tramadol para uso oftálmico |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ITUB20153104A1 (it) * | 2015-08-13 | 2017-02-13 | Sooft Italia S P A Contrada Molino 17 68333 Montegiorgio Fm | Composizione ed uso di collirio a base di inositolo per migliorare l'accomodazione visiva dei pazienti |
AR102172A1 (es) * | 2015-10-05 | 2017-02-08 | Química Luar S R L | Una composición farmacéutica bactericida y virucida |
RU2624901C2 (ru) * | 2015-10-05 | 2017-07-07 | Елизавета Геннадьевна Полунина | Средство для аппликационной анестезии с антисептическими, оптикокератопротективными свойствами и способ его применения в офтальмологии |
KR20190061047A (ko) | 2016-09-30 | 2019-06-04 | 마티 테라퓨틱스 인코포레이티드 | 안과 약제의 서방성 제형 및 그 용도 |
FI3996699T3 (fi) * | 2019-07-09 | 2023-08-01 | Farmalider Sa | Ibuprofeenin ja tramadolin yhdistelmä kivun lievitykseen |
WO2024010040A1 (ja) * | 2022-07-06 | 2024-01-11 | ロート製薬株式会社 | 眼科組成物 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2356762A1 (es) * | 2009-09-04 | 2011-04-13 | Farmalider S.A. | Composicion farmaceutica de ibuprofeno, tramadol y un aminoacido basico, procedimiento para su preparacion y utilizacion de la misma. |
CN102058581A (zh) * | 2010-11-30 | 2011-05-18 | 广东宏盈科技有限公司 | 一种眼科外用非甾体抗炎药 |
WO2013124498A1 (es) * | 2012-02-22 | 2013-08-29 | Farmauder, S.A. | Composición farmacéutica de ibuprofeno y tramadol para inyección |
WO2013150277A1 (en) * | 2012-04-05 | 2013-10-10 | Anant Sharma | Ophthalmic therapy |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB971700A (en) | 1961-02-02 | 1964-09-30 | Boots Pure Drug Co Ltd | Anti-Inflammatory Agents |
US3652589A (en) | 1967-07-27 | 1972-03-28 | Gruenenthal Chemie | 1-(m-substituted phenyl)-2-aminomethyl cyclohexanols |
GB1497044A (en) | 1974-03-07 | 1978-01-05 | Prodotti Antibiotici Spa | Salts of phenyl-alkanoic acids |
AU661723B2 (en) * | 1991-10-30 | 1995-08-03 | Mcneilab, Inc. | Composition comprising a tramadol material and a non-steroidal anti-inflammatory drug |
US20040224010A1 (en) * | 2002-11-15 | 2004-11-11 | Optime Therapeutics, Inc. | Ophthalmic liposome compositions and uses thereof |
TWI347201B (en) * | 2003-04-21 | 2011-08-21 | Euro Celtique Sa | Pharmaceutical products,uses thereof and methods for preparing the same |
CN1513442A (zh) * | 2003-06-26 | 2004-07-21 | 昆明市延安医院 | 精氨酸-布洛芬混合物的制法和用途 |
SI1888033T1 (sl) * | 2005-06-09 | 2014-06-30 | Meda Ab | Postopek in sestavek za zdravljenje vnetnih motenj |
CN101563074B (zh) * | 2006-10-20 | 2012-11-07 | 麦克内尔-Ppc股份有限公司 | 乙酰氨基酚/布洛芬组合 |
BRPI0810773A2 (pt) * | 2007-04-30 | 2014-10-07 | Adolor Corp | Composição farmacêutica, métodos para tratar dor em um mamífero, para tratar depressão em um mamífero, para tratar um distúrbio em um paciente, para fabricar um composto, e para inibir a captação de norepinefrina, composto, e, uso de uma composição. |
EP3799866A1 (en) * | 2011-04-05 | 2021-04-07 | Optosolve Research & Development Ltd | Ophthalmic treatments comprising tramadol |
-
2013
- 2013-10-11 ES ES201300963A patent/ES2540151B1/es active Active
-
2014
- 2014-10-08 MX MX2014012158A patent/MX355770B/es active IP Right Grant
- 2014-10-10 PT PT14380031T patent/PT2862565T/pt unknown
- 2014-10-10 AR ARP140103790A patent/AR097997A1/es not_active Application Discontinuation
- 2014-10-10 US US14/511,321 patent/US10292953B2/en active Active
- 2014-10-10 PL PL14380031T patent/PL2862565T3/pl unknown
- 2014-10-10 HU HUE14380031A patent/HUE040093T2/hu unknown
- 2014-10-10 RU RU2014140885A patent/RU2694369C2/ru active
- 2014-10-10 EP EP14380031.6A patent/EP2862565B1/en active Active
- 2014-10-10 BR BR102014025307-6A patent/BR102014025307B1/pt active IP Right Grant
- 2014-10-10 DK DK14380031.6T patent/DK2862565T3/en active
- 2014-10-10 ES ES14380031.6T patent/ES2685023T3/es active Active
-
2018
- 2018-08-03 HR HRP20181282TT patent/HRP20181282T1/hr unknown
- 2018-08-17 CY CY181100867T patent/CY1120642T1/el unknown
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2356762A1 (es) * | 2009-09-04 | 2011-04-13 | Farmalider S.A. | Composicion farmaceutica de ibuprofeno, tramadol y un aminoacido basico, procedimiento para su preparacion y utilizacion de la misma. |
CN102058581A (zh) * | 2010-11-30 | 2011-05-18 | 广东宏盈科技有限公司 | 一种眼科外用非甾体抗炎药 |
WO2013124498A1 (es) * | 2012-02-22 | 2013-08-29 | Farmauder, S.A. | Composición farmacéutica de ibuprofeno y tramadol para inyección |
WO2013150277A1 (en) * | 2012-04-05 | 2013-10-10 | Anant Sharma | Ophthalmic therapy |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2604816A1 (es) * | 2015-09-09 | 2017-03-09 | Farmalider, S.A. | Composición farmacéutica de tramadol para uso oftálmico |
WO2017042404A1 (es) * | 2015-09-09 | 2017-03-16 | Farmalider, S.A. | Composición farmacéutica de tramadol para uso oftálmico |
Also Published As
Publication number | Publication date |
---|---|
DK2862565T3 (en) | 2018-08-13 |
ES2685023T3 (es) | 2018-10-05 |
US10292953B2 (en) | 2019-05-21 |
US20150105468A1 (en) | 2015-04-16 |
BR102014025307A2 (pt) | 2015-09-29 |
MX2014012158A (es) | 2015-05-27 |
MX355770B (es) | 2018-04-30 |
RU2014140885A3 (es) | 2018-06-14 |
PT2862565T (pt) | 2018-10-16 |
AR097997A1 (es) | 2016-04-27 |
EP2862565A1 (en) | 2015-04-22 |
EP2862565B1 (en) | 2018-05-23 |
RU2014140885A (ru) | 2016-04-27 |
CY1120642T1 (el) | 2019-12-11 |
HUE040093T2 (hu) | 2019-02-28 |
ES2540151B1 (es) | 2016-02-29 |
BR102014025307B1 (pt) | 2021-11-03 |
HRP20181282T1 (hr) | 2018-10-05 |
RU2694369C2 (ru) | 2019-07-12 |
PL2862565T3 (pl) | 2018-10-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2540151A1 (es) | Composición farmacéutica de ibuprofeno y tramadol para uso oftálmico | |
CY1121203T1 (el) | Θεραπευτικες χρησεις της εμπαγλιφλοζινης | |
CL2017002527A1 (es) | Uso de agonistas de receptor de péptido formilo 2 para tratar enfermedades inflamatorias oculares. (divisional de solicitud n°2485-2015). | |
DOP2016000109A (es) | Formas sólidas de ácido {[5-(3-clorofenil) -3-hidroxipiridin-2-carbonil] amino} acético, composiciones, y usos de las mismas. | |
BR112015020804A2 (pt) | dispositivo fototerapeutico, método e uso | |
EA201800064A1 (ru) | 1,1,1-трифтор-3-гидроксипропан-2-ил карбаматные производные и 1,1,1-трифтор-4-гидроксибутан-2-ил карбаматные производные в качестве ингибиторов magl | |
EA201690212A1 (ru) | Способы лечения или профилактики офтальмологических патологических состояний | |
EA201590654A1 (ru) | Комбинация разагилина и придопидина для лечения нейродегенеративных нарушений, в частности болезни хантингтона | |
CL2016001918A1 (es) | Heteroaril amidas como inhibidores de agregación de proteína | |
UY35276A (es) | Nuevos compuestos que inhiben la actividad de Lp-PLA2 | |
BR112015004875A2 (pt) | formulações de anticorpo e seus usos | |
GT201600084A (es) | (aza) piridopirazolopirimidinonas e indazolopirimidinonas y su uso | |
BR112018006866A2 (pt) | compostos agonistas de ppar, composições farmacêuticas e métodos de uso dos mesmos | |
BR112015011898A2 (pt) | forma cristalina a da chidamida, método para preparar a forma cristalina a da chidamida, uso da forma cristalina a da chidamida, forma cristalina b da chidamida, método para preparar a forma cristalina b da chidamida, uso da forma cristalina b da chidamida e formulação farmacêutica para o tratamento de doenças relacionadas à diferenciação e proliferação celular | |
WO2016057658A8 (en) | Ppar agonists, compounds, pharmaceutical compositions, and methods of use thereof | |
EA201692402A1 (ru) | Лекарственные формы для местного применения и их использование | |
CL2016000019A1 (es) | Compuestos derivados de dihidroxifenilo deuterado o una sal de los mismos; composición farmacéutica que los comprende y su uso para el tratamiento de trastornos mediados por neurotransmisores tales como hipotensión, trastornos del sueño, enfermedad de alzheimer y depresión. | |
EA201691656A2 (ru) | Терапевтические способы с применением норибогаина и родственных соединений | |
BR112015021265A2 (pt) | métodos de aperfeiçoamento de uso para secretoglobinas humanas recombinantes | |
BR112017021583A2 (pt) | métodos para o tratamento de transtornos inflamatórios | |
BR112019002355A2 (pt) | composições e métodos para prevenção de acidente vascular cerebral em pacientes pediátricos com anemia falciforme | |
EA201792056A1 (ru) | Лечение пациентов с сахарным диабетом 2 типа | |
CL2015003460A1 (es) | Composiciones oftálmicas acuosas tópicas que contienen un derivado de 1h-indol-1-carboxamida y uso de estas para el tratamiento de una enfermedad oftálmica | |
BR112015017381A2 (pt) | agentes analgésicos oculares tópicos | |
EA201690574A1 (ru) | Применение пидотимода в лечении заболеваний, связанных с воспалением |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 2540151 Country of ref document: ES Kind code of ref document: B1 Effective date: 20160229 |